Synthesis and cytotoxic activities of usnic acid derivatives

Marc-Antoine Bazin1, Anne-Cécile Le Lamer, Jean-Guy Delcros

  • 1EA 4090 Substances lichéniques et photoprotection, UFR des Sciences Pharmaceutiques et Biologiques, Université de Rennes 1, 2 Avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France.

Insights

New usnic acid-amine conjugates show potent anticancer activity against various cancer cell lines. These compounds demonstrate cytotoxicity independent of the polyamine transport system and induce apoptosis.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Usnic acid is a natural compound with known biological activities.
  • Cancer remains a significant global health challenge requiring novel therapeutic agents.
  • Polyamines play crucial roles in cell growth and proliferation, making them targets for cancer therapy.

Purpose of the Study:

  • To synthesize and evaluate the anticancer potential of novel usnic acid-amine conjugates.
  • To investigate the mechanism of action, particularly the role of the polyamine transport system (PTS).
  • To identify promising drug candidates for cancer treatment.

Main Methods:

  • Synthesis of nine usnic acid-amine conjugates.
  • Cytotoxicity assays on murine (L1210) and human cancer cell lines.
  • Evaluation of drug activity in polyamine transport system (PTS)-proficient (CHO) and deficient (CHO-MG) cells.
  • Assessment of the effect of ornithine decarboxylase inhibition on conjugate activity.

Main Results:

  • Significant cytotoxicity was observed for several usnic acid-amine conjugates in L1210 cells.
  • The observed activities were independent of the polyamine transport system (PTS).
  • The most potent derivative, a 1,8-diaminooctane conjugate, showed broad activity across tested cancer cell lines and induced apoptosis.

Conclusions:

  • Usnic acid-amine conjugates represent a promising class of anticancer agents.
  • Their efficacy is not mediated by the polyamine transport system, suggesting a unique mechanism of action.
  • Further investigation into these compounds may lead to novel cancer therapeutics.

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...